StockData
Novartis AG logo

Novartis AG (NVS) income statement

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$150.47−0.75 (-0.50%)

Close on Nov 20, 2026Market cap $287.12BP/E 21.0Yield –

See a number that looks wrong?